DUXAP10 and hepatocellular carcinoma: By modulating the Wnt/β-catenin and PI3K/Akt signaling pathways, DUXAP10 has been demonstrated to influence the invasion and migration of HCC (Han et al., 2019) SMMC-7721 and HepG2 cells through the regulation of EMT.